vf
sampl
obtain
patient
shapu
n
patient
suffer
retin
detach
n
vf
sampl
patient
endophthalm
n
nonbacterialfung
infecti
uveiti
eg
herpesviru
toxoplasma
posterior
uveiti
n
includ
nonshapu
infecti
control
vf
sampl
surplu
specimen
collect
diagnost
therapeut
vitrectomi
shapu
vf
sampl
obtain
patient
treat
tilganga
institut
ophthalmolog
kathmandu
nepal
remain
vf
sampl
obtain
patient
enrol
rotterdam
eye
hospit
netherland
f
proctor
foundat
san
francisco
california
ensur
anonym
clinic
sampl
assign
sampl
number
clinic
identifi
attach
addit
pair
serum
vf
sampl
collect
prospect
written
inform
consent
obtain
patient
andor
parent
tilganga
institut
ophthalmolog
addit
shapu
patient
nonshapu
posterior
uveiti
patient
tabl
studi
procedur
perform
complianc
relev
law
institut
guidelin
accord
ethic
standard
declar
helsinki
nineteen
vf
sampl
obtain
endophthalm
n
shapu
n
patient
avail
viru
discoveri
studi
use
random
pcr
amplif
nucleic
acid
largescal
molecular
rna
dna
viru
screen
base
host
nucleic
acid
deplet
sequenceindepend
amplif
sequenc
partial
purifi
vfderiv
rna
dna
perform
vf
sampl
dilut
phosphatebuff
salin
essenti
describ
previous
total
nucleic
acid
extract
aliquot
vf
sampl
use
magna
pure
lc
total
nucleic
acid
isol
kit
magna
pure
lc
isol
station
roch
accord
manufactur
instruct
highli
conserv
genom
area
locat
downstream
tata
box
correspond
nucleotid
nt
prototyp
torqu
teno
viru
ttv
isol
nt
prototyp
torqu
teno
midi
viru
ttmdv
isol
nt
prototyp
torqu
teno
mini
viru
ttmv
isol
amplifi
use
nest
pcr
describ
previous
classif
anelloviru
amplicon
distinct
genera
human
alphatorqueviru
betatorqueviru
gammatorqueviru
base
assign
size
pcr
fragment
separ
electrophoresi
detect
use
genet
analyz
appli
biosystem
human
taqman
assay
develop
use
primer
probe
label
end
respect
reaction
carri
format
taqman
univers
pcr
master
mix
roch
primer
probe
isol
nucleic
acid
condit
use
amplif
minut
follow
minut
cycl
denatur
second
annealingextens
second
abi
prism
appli
biosystem
clone
ttv
amplicon
standard
also
taken
defin
amount
ttv
copiesml
vf
amplicon
purifi
use
msb
ht
pcrapacec
kit
invitek
gmbh
accord
manufactur
instruct
sequenc
perform
purifi
amplicon
use
big
dye
termin
cycl
sequenc
kit
appli
biosystem
genet
analyz
appli
biosystem
obtain
sequenc
screen
homolog
known
sequenc
deposit
genbank
http
wwwncbinlmnihgovgenbank
use
basic
local
align
search
tool
blast
blastn
tblastx
analysi
randomli
amplifi
amplicon
vf
focus
viru
discoveri
sequenc
interest
homolog
virus
infect
mammal
observ
multipl
align
creat
use
clustalx
phylogenet
analys
carri
molecular
evolutionari
genet
analysi
mega
version
beta
manner
similar
use
previou
ttv
studi
phylogenet
tree
calcul
use
neighborjoin
p
distanc
bootstrap
analysi
perform
replic
data
differ
condit
compar
use
fisher
exact
test
binomi
data
test
numer
data
differ
consid
signific
p
nineteen
vf
sampl
obtain
patient
endophthalm
n
shapu
n
determin
potenti
presenc
viral
pathogen
vfderiv
rna
dna
subject
random
pcr
amplif
subsequ
sequenc
approxim
amplicon
averag
length
bp
per
vfderiv
nucleic
acid
sampl
analysi
focus
identif
virus
infect
mammal
potenti
viral
nucleic
acid
sequenc
detect
endophthalm
sampl
shapu
vf
sampl
approxim
amplicon
high
homolog
human
herpesviru
identifi
endophthalm
sampl
amplicon
homolog
ttmv
identifi
shapu
sampl
second
shapu
sampl
amplicon
rang
size
approxim
bp
bp
homolog
differ
part
ttmv
ttmdv
genom
identifi
data
shown
ttv
famili
anellovirida
small
nonenvelop
virus
circular
singlestrand
dna
genom
neg
polar
kb
kb
long
famili
anellovirida
contain
genera
alpha
beta
gamma
delta
epsilon
eta
iota
theta
zetatorqueviru
alpha
beta
gammatorqueviru
genera
contain
anellovirus
infect
human
ttv
infect
commonli
acquir
earli
childhood
viru
establish
chronic
product
infect
longlast
detect
viremia
ttv
endem
worldwid
detect
blood
variou
tissu
bodi
includ
cerebrospin
bronchioalveolar
lavag
fluid
sampl
ttv
genu
alphatorqueviru
classifi
least
genotyp
nucleotid
diverg
consist
major
genet
group
group
sequenc
diverg
ttmv
genu
betatorqueviru
highli
diverg
group
propos
ttmdv
genu
gammatorqueviru
approxim
sequenc
divers
observ
across
fulllength
genom
corrobor
find
ttv
vf
shapu
patient
nest
pcr
specif
differenti
detect
human
anellovirus
genera
alpha
beta
gammatorqueviru
perform
set
vf
sampl
obtain
shapu
patient
n
nonshapu
infecti
diseas
control
patient
endophthalm
n
infecti
uveiti
n
vf
obtain
patient
retin
detach
n
use
noninfecti
control
sampl
figur
vf
sampl
retin
detach
patient
neg
ttv
ttmdv
ttmv
among
infecti
uveiti
patient
ttv
ttmv
detect
vf
sampl
wherea
ttmdv
detect
correl
presenc
anellovirus
initi
herpesviru
parasit
clinic
pictur
found
data
shown
among
endophthalm
patient
posit
ttv
posit
ttmdv
posit
ttmv
vf
shapu
patient
contain
either
multipl
anellovirus
virus
ttv
ttmdv
ttmv
detect
shapu
vf
sampl
preval
virus
vf
shapu
patient
significantli
higher
compar
nonshapu
patient
figur
notabl
vf
sampl
shapu
patient
posit
ttv
among
nonshapu
patient
endophthalm
case
also
anellovirus
vf
sampl
data
shown
next
perform
realtim
pcr
analysi
compar
intraocular
load
ttv
shapu
n
nonshapu
patient
n
sampl
figur
ttv
load
significantli
differ
patient
cohort
median
viral
load
ttv
genom
equival
copi
per
millilit
vf
note
ttvspecif
realtim
pcr
assay
less
sensit
compar
nest
pcr
describ
viral
load
realtim
pcr
could
determin
shapu
case
nonshapu
case
initi
ttvposit
vf
sampl
figur
data
shown
obtain
insight
presenc
anellovir
genom
vf
sampl
shapu
patient
genotyp
ocularderiv
ttv
shapu
nonshapu
patient
determin
shapu
describ
nepal
hypothes
exist
specif
shapuinduc
ttv
variant
genom
ttv
isol
share
low
dna
sequenc
homolog
howev
short
stretch
bp
intergen
nontransl
region
identifi
highli
conserv
among
human
ttv
isol
use
demonstr
ttv
infect
genotyp
clinic
isol
test
hypothesi
clone
sequenc
vfderiv
amplicon
clone
per
vf
sampl
particular
genom
region
shapu
patient
multipl
differ
ttv
variant
averag
variant
rang
observ
shapu
sampl
neighborjoin
phylogenet
tree
creat
use
ocularderiv
shapu
ttv
amplicon
correspond
sequenc
ttv
ttmdv
ttmv
strain
previous
deposit
genbank
databas
figur
shapuassoci
ttv
sequenc
show
similar
belong
phylogenet
clade
moreov
shapu
ttv
sequenc
sampl
often
group
togeth
suggest
patient
infect
multipl
differ
ttv
variant
even
genotyp
increas
ttv
preval
shapu
patient
may
owe
differ
geograph
origin
nonshapu
patient
includ
diseas
control
wherea
shapu
patient
recruit
nepal
nonshapu
patient
either
dutch
us
citizen
investig
potenti
confound
factor
pair
serum
vf
sampl
addit
shapu
patient
n
nonshapu
patient
n
includ
endophthalm
patient
prospect
collect
tilganga
institut
ophthalmolog
tabl
pair
serum
vf
sampl
nepales
shapu
nonshapu
patient
analyz
use
nest
anelloviru
pcr
preval
anellovirus
vf
patient
group
similar
observ
first
patient
cohort
analyz
figur
confirm
high
preval
anellovirus
shapu
vf
sampl
tabl
serum
sampl
howev
signific
differ
detect
ttv
ttmdv
ttmv
observ
patient
group
preval
anelloviru
viremia
high
patient
group
tabl
patient
ttv
threequart
ttmv
half
ttmdv
viremia
time
sampl
shapu
patient
presenc
anellovirus
pair
vf
serum
sampl
correl
except
shapu
case
patient
anelloviru
pcr
dispar
vfserum
pair
consist
alway
anelloviru
pcrneg
vf
sampl
virem
patient
tabl
ocular
inflamm
commonli
associ
bloodocular
barrier
perturb
specif
increas
barrier
permeabl
match
anelloviru
pcr
data
pair
vf
serum
sampl
suggest
anellovirus
detect
vf
may
origin
circul
anelloviru
virem
patient
address
option
genotyp
vf
serumderiv
ttv
pool
shapu
nonshapu
patient
multipl
differ
ttv
variant
detect
serum
averag
variant
rang
vf
averag
variant
rang
sampl
ttv
variant
detect
serum
vf
shapu
patient
nonshapu
patient
data
shown
suggest
anelloviru
detect
vf
sampl
may
origin
system
ttv
pool
potenti
breakdown
bloodretina
barrier
due
rel
low
sensit
ttv
taqman
assay
ttv
load
pair
vf
serum
sampl
could
determin
low
analyz
statist
data
shown
aim
current
studi
determin
whether
virus
might
causal
involv
potenti
blind
ocular
diseas
shapu
use
sequenceindepend
amplif
nucleic
acid
sequenc
presenc
anellovirus
vf
sampl
patient
shapu
demonstr
find
corrobor
nest
pcr
assay
show
significantli
higher
preval
human
anellovirus
ttv
ttmdv
ttmv
eye
shapu
patient
compar
diseas
control
sinc
discoveri
ttv
relat
anellovirus
approxim
year
ago
mani
investig
carri
unravel
epidemiolog
clinic
pathogen
properti
anelloviru
associ
sever
diseas
includ
multipl
sclerosi
rheumat
diseas
cancer
system
lupu
erythematosi
hepat
asthma
herein
present
data
show
presenc
anellovirus
vf
patient
ocular
diseas
indic
novel
associ
virus
uveiti
particularli
shapu
patient
analys
clinic
paramet
patient
characterist
avail
review
reveal
major
differ
shapu
nonshapu
patient
shapu
patient
usual
children
year
age
underw
therapeut
vitrectomi
commonli
within
first
week
diseas
treatment
choic
preserv
visual
acuiti
shapu
patient
nonshapu
patient
howev
adult
first
treat
symptomat
use
antibiot
antivir
andor
corticosteroid
therapeut
vitrectomi
appli
second
treatment
option
usual
multipl
week
onset
diseas
data
shown
herpesviru
infecti
uveiti
intraocular
viral
parasit
load
invers
correl
durat
diseas
mainli
owe
effect
local
immun
respons
evok
upon
intraocular
infect
signific
differ
intraocular
viral
load
ttv
pcrposit
shapu
nonshapu
vf
sampl
observ
unlik
diseas
durat
influenc
detect
anelloviru
high
incid
shapu
young
children
contrast
increas
risk
uveiti
increas
age
children
may
prone
ocular
infect
anellovirus
adult
previous
describ
viral
diseas
pandem
influenza
viru
absenc
anellovirus
vf
sampl
retin
detach
patient
suggest
associ
ocular
inflamm
ocular
anelloviru
infect
ocular
inflamm
caus
perturb
bloodocular
barrier
specif
barrier
permeabl
mani
model
retin
diseas
anelloviru
infect
caus
chronic
plasma
viremia
infect
individu
detect
anellovirus
vf
sampl
may
result
passiv
entri
bloodderiv
anellovirus
vitreou
caviti
due
breakdown
bloodretina
barrier
uveiti
patient
inde
shapu
nonshapu
patient
anellovirusposit
vf
also
ttv
ttmdv
andor
ttmv
viremia
moreov
median
ttv
load
vf
rel
low
compar
previous
describ
serum
virem
individu
observ
conjunct
phylogenet
analysi
ttv
pair
serum
vf
sampl
suggest
anellovirus
vf
sampl
shapu
nonshapu
patient
like
origin
system
ttv
pool
upon
inflammationinduc
disrupt
bloodocular
barrier
howev
exogen
sourc
anellovirus
vf
rule
exampl
vf
sampl
shapu
patient
ttmdv
pcr
posit
absenc
detect
ttmdv
viremia
tabl
scenario
epidemiolog
associ
epidem
shapu
season
presenc
white
moth
may
key
factor
explain
higher
preval
anellovirus
shapu
patient
ocularpenetr
caterpillar
tarantula
hair
shown
induc
sever
ocular
inflamm
notabl
shapu
patient
document
close
contact
white
moth
moth
hair
incident
detect
cornea
even
anterior
chamber
shapu
patient
manandhar
unpublish
observ
corneapenetr
moth
hair
could
caus
intraocular
inflamm
allow
passiv
entri
anellovirus
vitreou
caviti
bloodstream
altern
ocularpenetr
hair
may
contamin
anellovirus
result
direct
inocul
viru
eye
scenario
although
less
like
plausibl
anellovirus
also
detect
river
water
sewag
pollut
superfici
water
worldwid
conclus
data
present
demonstr
high
preval
ttv
ttmdv
ttmv
vf
sampl
shapu
patient
novel
anelloviru
diseas
associ
report
prove
virus
causal
involv
pathogenesi
uveiti
shapu
particular
exclud
ultim
experiment
infect
studi
appropri
anim
model
requir
determin
pathogen
role
anellovirus
develop
uveiti
